Alexander Kaltenborn1,2, Ulrich Martin Carl3, Tanja Hinsche3, Mirko Nitsche3,4, Robert Michael Hermann5,6. 1. Department of Orthopedic and Trauma Surgery, Federal Armed Forces Hospital Westerstede, Westerstede, Germany. 2. Core Facility Quality Management and Health Technology Assessment in Transplantation, Integrated Research and Treatment Center Transplantation (IFB-Tx), Hannover Medical School, Hannover, Germany. 3. Center for Radiotherapy and Radiooncology Bremen and Westerstede, Westerstede, Germany. 4. Department of Radiotherapy, Karl-Lennert Cancer Center, University of Schleswig Holstein, Campus Kiel, Kiel, Germany. 5. Center for Radiotherapy and Radiooncology Bremen and Westerstede, Westerstede, Germany. hermann@strahlentherapie-westerstede.com. 6. Department of Radiotherapy and Special Oncology, Hannover Medical School, Hannover, Germany. hermann@strahlentherapie-westerstede.com.
Abstract
PURPOSE: Low-dose external beam radiotherapy (ED-EBRT) is frequently used in the therapy of refractory greater trochanteric pain syndrome (GTPS). As studies reporting treatment results are scarce, we retrospectively analyzed our own patient collectives. PATIENTS AND METHODS: In all, 60 patients (74 hips) received LD-EBRT (6 × 0.5 Gy in 29 hips, 6 × 1 Gy in 45). The endpoint was the patient's reported subjective response to treatment. The influence of different patient and treatment characteristics on treatment outcome was investigated. RESULTS: At the end of LD-EBRT, 69% reported partial remission, 4% complete remission, no change 28%. A total of 3 months later (n = 52 hips), the results were 37, 33, and 30% and 18 months after LD-EBRT (n = 47) 21, 51, and 28%. In univariate analysis "inclusion of the total femoral head into the PTV" and "night pain before LD-EBRT" were correlated with symptom remission at the end of LD-EBRT, while "initial increase in pain during LD-EBRT" was significantly associated with treatment failure. In multivariable modeling "initial increase in pain" was identified as a risk factor for treatment failure (p = 0.007; odds ratio [OR] 0.209; 95% confidence interval [CI] 0.048-0.957), while "night pain" was an independent factor for remission (p = 0.038; OR 3.484; 95% CI 1.004-12.6). Three months after LD-EBRT "night pain" and "inclusion of the complete femoral neck circumference into the PTV" were predictive for remission. CONCLUSION: LD-EBRT represents a useful treatment option for patients suffering from GTPS. Three months after therapy two-thirds of the patients reported a partial or complete symptom remission. Especially patients who suffered from nocturnal pain seemed to benefit. Treatment appeared to be more effective when the entire circumference of the femoral neck was encompassed.
PURPOSE: Low-dose external beam radiotherapy (ED-EBRT) is frequently used in the therapy of refractory greater trochanteric pain syndrome (GTPS). As studies reporting treatment results are scarce, we retrospectively analyzed our own patient collectives. PATIENTS AND METHODS: In all, 60 patients (74 hips) received LD-EBRT (6 × 0.5 Gy in 29 hips, 6 × 1 Gy in 45). The endpoint was the patient's reported subjective response to treatment. The influence of different patient and treatment characteristics on treatment outcome was investigated. RESULTS: At the end of LD-EBRT, 69% reported partial remission, 4% complete remission, no change 28%. A total of 3 months later (n = 52 hips), the results were 37, 33, and 30% and 18 months after LD-EBRT (n = 47) 21, 51, and 28%. In univariate analysis "inclusion of the total femoral head into the PTV" and "night pain before LD-EBRT" were correlated with symptom remission at the end of LD-EBRT, while "initial increase in pain during LD-EBRT" was significantly associated with treatment failure. In multivariable modeling "initial increase in pain" was identified as a risk factor for treatment failure (p = 0.007; odds ratio [OR] 0.209; 95% confidence interval [CI] 0.048-0.957), while "night pain" was an independent factor for remission (p = 0.038; OR 3.484; 95% CI 1.004-12.6). Three months after LD-EBRT "night pain" and "inclusion of the complete femoral neck circumference into the PTV" were predictive for remission. CONCLUSION: LD-EBRT represents a useful treatment option for patients suffering from GTPS. Three months after therapy two-thirds of the patients reported a partial or complete symptom remission. Especially patients who suffered from nocturnal pain seemed to benefit. Treatment appeared to be more effective when the entire circumference of the femoral neck was encompassed.
Authors: Oliver J Ott; Marcus Niewald; Hajo-Dirk Weitmann; Ingrid Jacob; Irenaeus A Adamietz; Ulrich Schaefer; Ludwig Keilholz; Reinhard Heyd; Ralph Muecke Journal: Strahlenther Onkol Date: 2014-09-20 Impact factor: 3.621
Authors: Oliver J Ott; Oliver Micke; Ralph Mücke; Marcus Niewald; Franz Rödel; Ulrich Schäfer; M H Seegenschmiedt; Meritxell Arenas; Benjamin Frey; Udo S Gaipl Journal: Strahlenther Onkol Date: 2018-12-18 Impact factor: 3.621
Authors: Matthias G Hautmann; Ernst-Michael Jung; Lukas P Beyer; Christoph Süß; Felix Steger; Markus Weber; Fabian Pohl; Oliver Kölbl; Franz Josef Putz Journal: Strahlenther Onkol Date: 2018-10-30 Impact factor: 3.621
Authors: Oliver Micke; Eyup Ugrak; Stefan Bartmann; Irenaeus A Adamietz; Ulrich Schaefer; Rebecca Bueker; Klaus Kisters; M Heinrich Seegenschmiedt; Khashayar Fakhrian; Ralph Muecke Journal: Radiat Oncol Date: 2018-04-19 Impact factor: 3.481